Literature DB >> 985838

Receptor-blocking factor present in immune serum resembling auto-anti-idiotype antibody.

R B Bankert, D Pressman.   

Abstract

Previous studies have shown that rabbit antibody-forming cells in the primary and secondary response possess cell-associated antigen-binding receptors. In the present study, we demonstrate that a factor appears in the serum of rabbits following immunization which inhibits the antigen binding of up to 60% of the receptor-bearing antibody-forming cells in both the primary and secondary response. These observations were made on lymph node cells from rabbits primed with either sheep red blood cells (SRBC)3 or 3-nitro-4-hydroxy-5-iodophenylacetic acid coupled to keyhole limpet hemocyanin (NIP-KLH). The inhibitory activity is not associated with anti-SRBC or anti-NIP antibody. In the primary response to SRBC, the antigen binding by day 6 antibody-forming cells is inhibited by the autologous days 7 to 10 inactivated and absorbed serum. In the secondary response to SRBC, the inhibitory factor peaks in the serum around day 10. Later, in both the primary and secondary immune response to SRBC, the inhibitory activity of the serum decreases rapidly. In the primary response to NIP-KLH, the inhibitory activity of the immune sera increased from day 7 through day 14. The receptor-inhibiting factor is antigen specific since the serum from SRBC-primed rabbits inhibits SRBC binding by anti-SRBC antibody-forming cells, but it does not inhibit NIP binding by anti-NIP antibody-forming cells. Similarly, serum from NIP-KLH-primed rabbits inhibits NIP binding by anti-NIP antibody-forming cells, but does not inhibit the SRBC receptor on the anti-SRBC antibody-forming cells. The inhibition is not due to the presence of antihapten or anti-SRBC antibody competing with receptor sites, since the immune sera from one SRBC-primed animal inhibit antigen binding of its own antibody-forming cells, but do not inhibit the antigen binding of antibody-forming cells from other SRBC-primed rabbits.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 985838

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Characterization of anti-Fab' antibodies in human sera: identification of soluble immune complexes that contain hidden anti-KLH and blocking anti-immunoglobulins following immunization with keyhole limpet haemocyanin.

Authors:  H H Birdsall; R D Rossen
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

2.  Platelet receptors for the Streptococcus sanguis adhesin and aggregation-associated antigens are distinguished by anti-idiotypical monoclonal antibodies.

Authors:  K Gong; D Y Wen; T Ouyang; A T Rao; M C Herzberg
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

3.  Anti-idiotypes to anti-Lolp I (Rye) antibodies in allergic and non-allergic individuals. Influence of immunotherapy.

Authors:  R Bose; D G Marsh; G Delespesse
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

4.  Selective elimination of idiotype-binding cells in vivo by a drug-idiotype conjugate demonstrates the functional significance of these cells in immune regulation.

Authors:  M M Abu-Hadid; R B Bankert; G L Mayers
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

5.  Detection of auto-anti-idiotypic antibodies to Lol p I (rye I) IgE antibodies in human sera by the use of murine idiotypes: levels in atopic and non-atopic subjects and effects of immunotherapy.

Authors:  J Hébert; D Bernier; W Mourad
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

6.  Feedback suppression of the immune response in vitro. II. IgVH-restricted antibody-dependent suppression.

Authors:  R H Zubler; B Benacerraf; R N Germain
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

7.  Production of auto-anti-idiotypic antibody during the normal immune response to TNP-Ficoll. II. Hapten-reversible inhibition of anti-TNP plaque-forming cells by immune serum as an assay for auto-anti-idiotypic antibody.

Authors:  E A Goidl; A F Schrater; G W Siskind; G J Thorbecke
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

8.  Antigen receptors on murine T lymphocytes in contact sensitivity. III. Mechanism of negative feedback regulation by auto-anti-idiotypic antibody.

Authors:  J W Moorhead
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

9.  Production of auto-anti-idiotypic antibody during the normal immune response to TNP-ficoll. I. Occurrence in AKR/J and BALB/c mice of hapten-augmentable, anti-TNP plaque-forming cells and their accelerated appearance in recipients of immune spleen cells.

Authors:  A F Schrater; E A Goidl; G J Thorbecke; G W Siskind
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.